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COLOR DOPPLER SONOGRAPHY WITH CONTRAST
IN THE DIFFERENTIATION OF OVARIAN TUMORS
Eduardo Cardoso Blanco, Ayrton Roberto Pastore, Angela Maggio da Fonseca,
Filomena Marino Carvalho, Jesus Paula Carvalho and José Aristodemo Pinotti
BLANCO EC et al. - Color Doppler sonography with contrast in the differentiation of ovarian tumors. Rev. Hosp. Clín. Fac.
Med. S. Paulo 58(4):185-192, 2003.
The objective of this study was to differentiate benign ovarian tumors from malignant ones before surgery using color
and pulsed Doppler sonography, and to compare results obtained before and after use of contrast medium, thereby verifying
whether contrast results in an improvement in the diagnostic sensitivity.
METHODS: Sixty two women (mean age 49.9 years) with ovarian tumors were studied, 45 with benign and 17 with
malignant tumors. All women underwent a transvaginal color Doppler ultrasonographic exam. A study of the arterial
vascular flow was made in all tumor areas, as well as an impedance evaluation of arterial vascular flow using the resistance
index.
RESULT: Localization of the vessels in the tumor revealed a greater proportion of malignant tumors with detectable
internal vascular flows (64%) than benign tumors with such flows (22%). There was a considerable overlap of these findings.
The use of contrast identified a greater number of vessels with confirmation in the totality of tumors, but did not improve the
Doppler capacity in tumoral differentiation. Malignant tumors presented lower values of resistance index than the benign
ones, whether or not contrast was used. The cutoff value for resistance index that better maximized the Doppler sensitivity
and specificity was 0.55. Through this value, an increase of the sensitivity after contrast use was obtained, varying from 47%
to 82%, while specificity remained statistically unchanged.
CONCLUSION: Although the injection of a microbubble agent improved the sensitivity of the method detecting
vascularization of tumors, a positive finding for vascularization by this method was not clinically useful in the differentiation
of benign and malignant ovarian tumors.
DESCRIPTORS: Transvaginal ultrasound. Color Doppler sonography. Adnexal mass. Ovarian neoplasms. Contrast
medium.
Considerable evidence indicates
that neovascularization is responsible
for the tumoral growth and invasion1.
Ultrasonography with color and pulsed
Doppler provides dynamic information
concerning the distribution of tumor
vessels and their impedance value
through the determination of resist-
ance (RI) and pulsatility (PI) indices.
Preliminary data suggests that it is
possible to detect vascular changes as-
sociated with angiogenesis in early
ovarian cancer through this tech-
nique2. A possible explanation for
these changes is that the new blood
vessels present in the carcinomas have
limited muscular tonus due to the ab-
sence of the medial layer and that to-
gether with numerous existing arterio-
venous shunts, they would be respon-
sible for the low impedance registered
by the RI and PI indices. However, this
method presents some restrictions as-
sociated with the inaccessibility to the
small caliber vessels, thus demonstrat-
ing low sensitivity for the intended
purpose3. The advent of echo-enhanc-
ing substances for endovenous use,
according to experiences in other or-
gans4, would allow better visibility of
these vessels, thereby helping in the
differentiation of the neoplastic proc-
ess.
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The objective of this study was to
differentiate benign from malignant
tumors prior to surgery by using color
and pulsed Doppler and to compare
the results before and after use of con-
trast so that any improvements in re-
sulting diagnostic sensitivity and
specificity could be verified.
MATERIAL  AND  METHODS
This study comprised 62 women
with ages varying from 13 to 84 years
(average 49.9 years) with
histologically confirmed ovarian
tumors, 45 benign and 17 malignant
ones. All patients underwent surgery,
and the classification of histologic
findings was made according to the
World Health Organization criteria.
The patients signed a consent form, as
approved by the Research Ethics Com-
mittee of our University.
Contrast medium
All patients received the ultra-
sound contrast agent Levovist® 400
mg/mL (8 mL) intravenously via pe-
ripheral vein. Levovist® (Schering AG,
Berlin FRG) is a suspension of espe-
cially manufactured galactose contain-
ing 99.9% galactose microparticles
and a very low concentration of pal-
mitic acid. Each vial contained 4 g of
microparticles, and after suspension in
water for injection was administered
as a bolus via an 18-gauge plastic can-
nula inserted into the arm vein (injec-
tion speed: 1-2 mL/second continu-
ously). This was followed by an addi-
tional 10 mL of physiological saline
solution to flush the cannula using the
same injection rate. A comparison was
made of the Doppler sonographic find-
ings before and after injection of
Levovist®. Although repetitive injec-
tions of the product were permitted (up
to the maximum of 6 units) none of the
cases required an additional injection.
Equipment and analysis of color
Doppler signals
The ultrasonographic transvaginal
exam with Doppler was performed with
a commercially available scanner, GE
LOGICTM 500 , version 2.0, with ab-
dominal and transvaginal transducers
of 3.5 MHz and 5.0 MHz respectively.
A Doppler filter of 50 Hz was used to
eliminate low-frequency signals re-
sulting from vessel wall motion. The
color Doppler gain was increased un-
til noise appeared and then was re-
duced until the noise was totally sup-
pressed (usually this was a 50% reduc-
tion). Whenever the tumors exceeded
10 cm diameter, the study was com-
pleted via transabdominal ultrasonog-
raphy. In premenopausal patients, the
examination was performed between
the 3rd and 10th days of the menstrual
cycle in order to avoid the effects on
the ovarian vascularization provoked
by ovulation and the luteal body. The
settings of the scanner controls were
not altered after the injection of con-
trast. Vascular arterial flows were stud-
ied in all tumor areas, as was the im-
pedance of vascular flows using RI de-
termination. The vessels were classi-
fied as internal or peripheral according
to their location. When the flow was
measured in more than one vessel, the
vessel with the lowest RI was chosen
for study.
The video output of the scanner
was tape recorded starting at 5 seconds
prior to injection and continuing un-
til the intensity of the color Doppler
signals was subjectively judged to re-
turn to the base-line level. The number
of vessels was evaluated within 10 mm
of the tumors in the peripheral and
central location.
The same examiner performed all
ultrasonographic examinations.
The chi-square test was used to sta-
tistically evaluate the quantitative
variables. A canonical correlation was
applied to the sets of variables ob-
served in both methods (with and with-
out contrast) aiming at evaluating
their relationship. The classification
power regarding malignancy of the
method used, with or without contrast,
was analyzed with focus on the
specificity and sensitivity of measure-
ments that were based on Youden’s in-
dex and the receiver operating charac-
teristics (ROC). A p value below 0.05
was considered to be a statistically sig-
nificant difference.
RESULTS
When determining the RI by Dop-
pler technique without the use of con-
trast, it was possible to reproduce ar-
terial flow in only 45 cases, which
were therefore used for the compara-
tive analysis between the 2 examina-
tion modalities, without and with con-
trast (Table 1).
After injection of the contrast dur-
ing the color Doppler exam, enhance-
ment of vascular signals presented by
the adnexal masses was found at a
mean time of 25 seconds ±14 (SD), this
effect remaining for a variable period
of time of 185 seconds ±45 (SD). All
patients presented an increase of Dop-
pler sign intensity, with the appearance
of new vessels in 77% of the tumors
(Figs. 1, 2).
Regarding the RI, the measures of
central tendency (mean) and of vari-
ability (standard deviation) observed
in the benign and malignant tumor
groups are presented in table 2.
Statistically significant differences
(p < 0.001) were observed between the
average values for both RI1 and RI2
in the benign vs. malignant compari-
sons. The average values of RI1 and
RI2 were not significantly different in
either the benign or the malignant
tumor group comparisons (Table 2).
Regarding vessel location in
tumors, a higher proportion of malig-
nant tumors had internal vascular flows
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Figure 1 - Serous cystadenoma of the ovary. (a) Cystic formation of
anechoic contents with presence of heterogeneous septa and lack of
blood vessels at transvaginal color Doppler ultrasonography. (b) After
administration of echographic contrast, very few vessels of peripheral
location were identified.
Figure 2 - Mucinous cystadenoma of the ovary. (a) Cystic formation
of irregular walls, predominant anechoic of contents with discreet
echogenic points (debris) in its interior; presence of numerous
heterogeneous and confluent septations. Color Doppler shows rare
blood vessels of peripheral location. (b) After use of contrast, an increase
of the vascular signal with the appearance of multiple vessels in the
interior septa and in the tumor periphery was noted.
within a solid component or septation
(64%) than did benign tumors with in-
ternal flows (22%). A significantly
greater number (c2 = 10.06, p = 0.0065)
of benign compared to malignant
tumors had peripheral flow without evi-
dence of internal flow (Table 1). The use
of contrast allowed the identification of
a greater number of centrally located
vessels in both groups of tumors, with
this increase being more evident in be-
nign tumors, in contrast with the results
obtained without the use of contrast
(Fig. 2).
Whether or not contrast was used,
the malignant tumors had smaller RI
values than the benign ones did (Ta-
ble 2).
Table 1 - Histologic diagnosis and results of blood flow distribution in 62 ovarian
tumors without use of contrast.
Pathologic Diagnosis Number Vessels
Absent Peripheral Central
Benign
Cystadenoma 25 11 12 2
Endometrioma 3 3
Dermoid cyst 9 3 2 4
Thecoma 1 1
Fibroma 1 1
Cystadenofibroma 4 1 2 1
Others 2 1 1
Malignant
Cystadenocarcinoma 10 1 9
Borderline 5 2 2 1
Clear cell carcinoma 1 1
Granulosa cell tumors 1  1
188
REV. HOSP. CLÍN. FAC. MED. S. PAULO 58(4):185-192, 2003Color Doppler sonography with contrast
Blanco EC et al.
Table 4 - Specificity, sensibility and predictive positive (PPV), and negative
(PNV) values of the classification based on vessel localization by the Doppler
technique without and with contrast
Color Doppler  Sensibility  Specificity PPV PNV Youden
Without contrast 65 78 52 85 42
With contrast 88 47 38 91 35
Note: Values are shown as percentages.
Table 3 - Sensibility, specificity, predictive positive (PPV), and negative (PNV)
values of Doppler without and with contrast for RI = 0.55
RI Sensibility Specificity PPV PNV Youden
Without contrast 47 93 78 78 40
With contrast 82 89 80 93 71
Note: Values are shown as percentages.
Table 2 - Averages and confidence intervals for RI values obtained as a result of
using the Doppler technique without contrast (RI1) and with contrast (RI2)
 Method  p  Diagnosis Average  Range
 RI1 <0.001  Malignant 0.565 0.38 – 0.81
 Benign 0.773 0.42 – 1
 RI2 <0.001  Malignant 0.461 0.33 – 0.57
 Benign 0.712 0.31 – 0.89
Note: The p value (descriptive level) is related to the Fisher’s exact test for comparison of
averages.
The cutoff RI value that better
maximized the Doppler sensitivity and
specificity was 0.55, as demonstrated
by the use of receiver operating char-
acteristics (ROC) methodology.
It was noted that the Youden’s in-
dex for all cutoff RI values was higher
when the contrast was used. The com-
parison of sensitivity values for both
methods, when considering the 0.55
cutoff value, showed a significant dif-
ference at the 8% level (the chi-square
test was applied with the Yates’ correc-
tion factor), thereby confirming the su-
perior Doppler results when using con-
trast, based on the Rl determination
(Table 3).
When the internal flow was used as
an indicator of malignancy, the sensi-
tivity and specificity for internal flow
versus either peripheral or no flow
through color Doppler were 65% and
78%, respectively. After use of the con-
trast, the sensitivity and specificity
were 88% and 47% respectively (Ta-
ble 4).
As it can be seen, the sensitivity
and specificity values of the color
Doppler are low, independent of the
use or not of the contrast for the clas-
sification of the tumors. There is no
evidence that the increase of sensitiv-
ity observed with the use of contrast
is significant (χ2=1.47, p = 0.2252,
with Yates’ correction).
DISCUSSION
The analysis of the epidemiologi-
cal aspects of ovarian cancer has gen-
erated a great deal of interest, espe-
cially regarding the detection and
characterization of the ovarian masses
through radiological imaging. Since
1958, when for the first time Donald
identified a voluminous pelvic-ab-
dominal ovarian cyst ultrasonogra-
phically, this technique has been sys-
tematically used in differentiating be-
tween benign and malignant tumors5.
Although the transvaginal route is
presently considered to produce re-
sults that are sensitive for the detection
of malignancy, the diagnostic confi-
dence is not sufficient to obviate in-
vasive procedures like laparoscopy
and laparotomy. Thus, notwithstand-
ing the efforts for improving the diag-
nostic accuracy, many studies have
demonstrated that morphological
evaluation of transvaginal ultrasound
has found 80% to 90% sensitivity and
from 65% to 95% specificity6-8.
Color and pulsed Doppler have
been widely investigated and proposed
as possible means to augment ultra-
sonography in differentiating adnexal
masses. Unfortunately, there is much
controversy in the literature regarding
the actual utility of the Doppler tech-
niques for this application.
The presence and localization of
the blood flow demonstrated through
ultrasonography with color Doppler
were initially used in an attempt to
characterize ovarian masses9-12.
Fleischer et al.10 found statistically
significant differences in the location
of blood vessels in benign lesions,
where they tend to be peripheral, com-
pared to malignant lesions where they
tend to be central. Our data also
showed a significantly higher percent-
age of malignant compared with be-
nign tumors with internal flow. Simi-
larly, the presence of a peripheral lo-
cation of vessels or their absence is
better related to benignity (PNV=85%).
It is interesting to point out that 88%
of the tumors in our study in which no
blood flow was observed were benign
(n = 15). Previous studies using Dop-
pler technology also reported the rar-
ity of identifying flows in predomi-
nantly benign ovarian masses12-15.
As a result of this and other works,
it can be concluded that a significant
number of tumors, either of benign or
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malignant nature, do not present blood
vessels at ultrasonographic evaluation
with Doppler technology. The im-
proper concept of “lack of blood flow”
in benign tumors presented by some
authors8,16-18 could be resulting from
technical limitations associated with
Doppler ultrasound rather than from
phenomena actually related to angio-
genesis. Thus, care must be taken when
considering whether the absence of
vascularization is to be used as a cri-
terion of assessment, since information
revealed through Doppler ultrasonog-
raphy is highly dependent on varia-
tions in technology and could easily
change as technology improves.
Currently, the use of some new tech-
nological resources has been funda-
mental for the increase in the detection
of blood vessels, and consequently for
the diagnostic accuracy of Doppler
use in the differentiation of pelvic
masses. The first resources that were of
technological origin did not always
have satisfactory results with the use
of amplitude Doppler (Angio®,
Power®, Energy®, Power-Angio, etc.).
Subsequently, based on experiences
with other organs19-26, results have been
obtained by applying echo-enhancer
agents via intravenous administration.
In this connection, the use of
LevovistÒ permitted the identification
of new blood vessels in tumors that
had undetectable vascular flow ini-
tially and in other tumors that already
had revealed vascular flow of periph-
eral distribution. In 12 cases of the lat-
ter, the new localization (central) was
chosen for diagnostic purposes. Al-
though more vessels were detected, the
use of contrast did not improve the
method’s capacity for predicting ma-
lignancy. Whether or not contrast is
used, color Doppler showed a limited
utility in the differentiation of ovarian
tumors.
When determining RI, signifi-
cantly lower values were registered in
malignant tumors as compared with
the benign ones, independent of the
use or not of contrast (Table 2). Con-
siderable overlap of RI values was ob-
served between the 2 groups of tumors,
thus confirming the findings in other
publications27-33. The lower RI values
found in both groups of tumors after
use of contrast would result from the
detection of vascular signs of low am-
plitude and obviously lower resistance
that were not detected by the conven-
tional Doppler technique.
In contrast with the first studies
performed with pulsed Doppler in
ovarian tumors16,34, where high sensi-
tivity (96%) and specificity (95%) in
the identification of malignant tumors
were obtained with RI <0.40 values,
later works questioned the veracity of
these findings. Thus, authors such as
TEKAY & JOUPILLA14 obtained, for a RI
cutoff value of 0.50, 46% sensitivity
and false positive rates of 11% in the
detection of malignancy. The results of
SCHNEIDER et al.35, for RI <0.40 values
were remarkably similar. Subsequent
studies have also showed low rates of
detection for ovarian cancer when us-
ing different cutoff values36-39. The
false positive rates in these investiga-
tions varied from 2% to 48%.
In the population covered by this
study, the discriminatory power range
of RI in the differentiation of tumors
was between the 0.50 and 0.60 values,
from which 0.55 was the one that best
maximized the sensitivity and
specificity simultaneously. For this
cutoff value, the pulsed Doppler with-
out and with contrast showed
specificity rates statistically similar to
93% and 89%, respectively.
A variety of benign lesions might
lead to an erroneous diagnosis, includ-
ing teratomas34, endometriomas40, and
thecomas41. In these studies, the pres-
ence of these types of tumors was con-
firmed following initial detection us-
ing pulsed Doppler.
A significant increase in sensitiv-
ity (from 47% to 82%) was observed
after administration of the contrast
agent, leading to a significant differ-
ence at the level of 8% (chi-square test
with Yates’ correcting factor). The pri-
mary clinical usefulness of this tech-
nique is associated with reliability of
the method for predicting benignity
(PNV for malignity = 93%). However,
the problem still persists regarding the
identification of malignity.
CONCLUSION
The use of echo-enhancing agents
such as Levovist considerably im-
proved the performance of the Doppler
ultrasonographic technique through the
increase of the vascular signal, thereby
permitting better identification of the
blood vessels and analysis of the im-
pedance standard of the blood flow
originating from them. Although our
data show that statistical statements can
be made about benign and malignant
tumors following the use of contrast
agents, they are of little clinical use, es-
pecially in the context of evaluating an
individual patient, because of the low
sensitivity that is still present.
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RESUMO
pesquisa de fluxo vascular foi realiza-
do em todas as áreas tumorais, assim
como a avaliação da impedância atra-
vés do índice de resistência.
RESULTADOS: A localização dos
vasos no tumor revelaram uma maior
proporção de fluxo vascular interno
detectável nos tumores malignos
(64%) do que nos tumores benignos
(22%). Houve entretanto uma conside-
rável sobreposição destes achados. O
uso de constrate foi capaz de identifi-
car um grande número de vasos na to-
talidade dos tumores, mas não melho-
rou a capacidade do Doppler na dife-
renciação entre tumores benignos e
malignos. Os tumores malignos apre-
sentaram valores mais baixos de índi-
ce de resistência.IR do que os benig-
nos, independentemente do uso de
BLANCO EC e col. - Ultra-sonografia
com Doppler colorido e uso de
contraste na diferenciação dos
tumores ovarianos. Rev. Hosp.
Clín. Fac. Med. S. Paulo 58(4):
185-192, 2003.
O objetivo deste estudo foi dife-
renciar tumores ovarianos benignos e
malignos antes da cirurgia através da
ultra-sonografia com uso de Doppler
colorido pulsátil e comparar os resul-
tados obtidos antes e após o uso de
contraste.
MÉTODO: Foram estudadas ses-
senta e duas mulheres (idade média de
49,9 anos) com tumores ovarianos, sen-
do 45 benigos e 17 malignos. Todas
foram submetidas a ultra-sonografia
transvaginal com Doppler colorido. A
contraste. O valor de corte do índice
de resistência. que maximizou a sen-
sibilidade e a especificidade do
Doppler foi de 0,55. Com este valor foi
obtido um aumento na sensibilidade
após o uso de contraste, variando de
47% a 82 %, enquanto a especifici-
dade se manteve equivalente.
CONCLUSÃO: Embora a injeção
de agentes produtores de microbolhas
aumentem a sensibilidade do método
na diferenciação da natureza do tumor,
este valor não se mostrou clinicamen-




Massas anexiais. Neoplasia ovaria-
na. Meios de contraste.
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